David Sidransky
CIK: 0001277161
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About SIDRANSKY DAVID
SIDRANSKY DAVID (SEC CIK 0001277161) files insider reports with the SEC as Director of ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG), Director of Galmed Pharmaceuticals Ltd. (GLMD) and Director of CHAMPIONS ONCOLOGY, INC. (CSBR).
Signal8 holds 5 ownership filings by SIDRANSKY DAVID (3 Form 3, 2 Form 4), filed between Nov 18, 2024 and Mar 23, 2026. Those filings report 2 transactions, from Nov 12, 2024 to Nov 5, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on SIDRANSKY DAVID's filings is in HACKENSACK, NJ.
Recent filings by SIDRANSKY DAVID
Other insiders filing for ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
- Miyara Faical, Chief Business Officer
- Zhai Yifan, Chief Medical Officer
- Yang Dajun, Chairman and CEO
- Misra Veet, Chief Financial Officer
- Cao Jin, Chief Accounting Officer
- Wei Ren, Director